Source: EURLEX
Language: en
Format: md

Judgment of the General Court (Second Chamber) of 15 May 2024 –  
Cellphenomics v EUIPO (CellCompDx)

(Case T‑512/23) (
[1](#t-ECR_62023TJ0512_INF_EN_01-E0001)
)

(EU trade mark – Application for EU word mark CellCompDx – Absolute ground for refusal – Descriptive character – Article 7(1)(c) of Regulation (EU) 2017/1001)

| 1. | EU trade mark – Definition and acquisition of the EU trade mark – Absolute grounds for refusal – Marks consisting exclusively of signs or indications which may serve to designate the characteristics of a product or service – Assessment of the descriptive character of a sign – Criteria  (European Parliament and Council Regulation 2017/1001, Art. 7(1)(c))  (see paragraphs 13-15, 20, 29, 30, 46) |

| 2. | EU trade mark – Definition and acquisition of the EU trade mark – Absolute grounds for refusal – Marks consisting exclusively of signs or indications which may serve to designate the characteristics of a product or service – Word mark CellCompDx  (European Parliament and Council Regulation 2017/1001, Art. 7(1)(c))  (see paragraphs 21, 27, 31, 34, 35, 39, 42) |

| 3. | EU trade mark – Definition and acquisition of the EU trade mark – Assessment of the registrability of a sign – EU rules only taken into account – Decisions of national authorities not binding on EU bodies  (European Parliament and Council Regulation 2017/1001)  (see paragraph 25) |

Operative part

The Court:

| 1. | Dismisses the action; |

| 2. | Orders each party to bear its own costs. |

---

(
[1](#c-ECR_62023TJ0512_INF_EN_01-E0001)
) [OJ C 36, 9.10.2023](./../../../legal-content/EN/AUTO/?uri=OJ:C:2023:036:TOC)

[Top](#document1)